Cannabis company Panaxia first in Europe approved to market inhalable cannabis solution

German regulators have approved Panaxia, an Israeli medical cannabis company, to market inhalable cannabis products for vaporisers. Along with German pharmaceutical company Neuraxpharm, Panaxia has become the first company to receive such approval in Europe. The products will be able to be prescribed by physicians who are authorised to issue medical cannabis.